Interestingly, they also showed that edited peptide-specific tumor-infiltrating lymphocytes (TILs) infiltrate and kill melanoma tumor cells in vivo, suggesting that ADAR1 could have dual roles as an oncogene, and indirectly, promote TIL-specific tumor cell destruction [39]. The gene discussed is ADAR; the disease is neoplasm.